Skip to main content
PLOS One logoLink to PLOS One
. 2025 May 2;20(5):e0321394. doi: 10.1371/journal.pone.0321394

Exploring canine’s olfactive threshold in artificial urine for medical detection

Michelle Leemans 1,*,#, Sara Hoummady 2,#, Emmanuelle Boutin 1, Adeline Giganti 3, Laetitia Maidodou 4,5, Vincent Cuzuel 6, Sabrine Ajili 3, Damien Steyer 4, Caroline Gilbert 7,8, Isabelle Fromantin 3
Editor: Etsuro Ito9
PMCID: PMC12047819  PMID: 40315287

Abstract

Canine olfaction is increasingly studied as a tool for detecting cancer and other diseases. Previous pilot studies have demonstrated that dogs can effectively distinguish positive samples from negative samples in humans with breast cancer, achieving sensitivity rates as high as 100%. However, questions remain about dogs’ ability to detect low concentrations of volatile organic compounds in complex medium. While dogs’ detection thresholds for isoamyl acetate using a mineral oil substrate have been studied, there are no current studies on their detection limits using more complex substrates like urine, relevant in clinical settings. This pilot study aimed to evaluate the olfactory threshold of dogs using artificial urine with various concentrations of isoamyl acetate.

Two dogs were trained to detect isoamyl acetate, initially using water as the substrate during the training phase, and subsequently using artificial urine during the testing phase, under single and double-blinded conditions. The dogs were trained to indicate the presence of isoamyl acetate solutions by sitting in front of the positive sample and ignoring controls. Training and testing occurred in a controlled environment, maintaining consistency with the same two handlers, a standardized methodology, and positive reinforcement with toy rewards. Based on double-blind performances, results showed a minimum detection threshold of 6.7 x 10-9 Molar (M) for Nougaro (Springer Spaniel) one dog and 2.1 x 10-7M for Prince (Labrador Retriever). The sample age did not affect performance. However, the position of the cone did, with higher failure rates for the first cone compared to the other three. These findings underscore the potential of trained dogs to detect volatile organic compounds at very low concentrations in complex substrates, supporting their use in clinical diagnostics.

Introduction

In 2022, cancer affected nearly 20 million people worldwide and resulted in about 9.7 million deaths, with lung cancer being the most prevalent, followed by breast, colorectal, and stomach cancers [1]. Although screening programs are in place, they sometimes miss early-stage cancers and often target specific age groups, such as 50–65 years of age, leaving gaps in early detection and management for other populations. Additionally, not everyone has access to these screening programs, particularly in resource-limited settings.

Dogs have demonstrated the ability to detect a range of complex targets, including narcotics, explosives, and various diseases [2]. Recent research has explored the potential of canine olfaction as a complementary cancer detection method [3]. Their potential for identifying cancers—such as breast, cervical, colorectal, ovarian, and stomach—has garnered significant interest due to their high sensitivity and specificity [4]. Canine detection sensitivity ranges from 17% to 100%, with specificity varying based on individual dogs’ anatomical and training factors [5]. This capability is linked to their ability to detect volatile organic compounds (VOCs) associated with disease states [6].

VOCs, low molecular compounds that easily evaporate at room temperature [7], show great potential for non-invasive cancer screening using trained dogs. While gas chromatography coupled with mass spectrometry (GC-MS) remains the gold standard for VOC detection, its practical application is limited by high costs, time-intensive processes, and lack of portability [6]. In contrast, using dogs for VOC detection offers a simpler, non-invasive, and potentially low-cost method. VOC canine screening can be performed in various settings, making it accessible even in resource-limited environments. The canine olfactory detection threshold—the minimum concentration at which an odorant can be reliably detected—varies widely [8]. For example, thresholds for amyl acetate range from 40 parts per billion (ppb) to 1.5 parts per trillion (ppt) in mineral oil [8], possibly influenced by factors such as genetic variation, training, methodology [9,10] or even microbiota [11,12]. To put 1 ppt into perspective, it is equivalent to dissolving one grain of sugar in an Olympic-sized swimming pool. One of the major drawbacks of using dogs in large-scale canine detection programs, such as COVID-19, is their limited concentration span, which we have set to 30 minutes per session. However, by optimizing the screening process, many samples can be processed within this time frame, making the method potentially efficient and promising for large-scale use.

The choice of the substrate is crucial in experimental setups, particularly because some biological samples (i.e.,: urine, sweat) are valuable in clinical settings for potential early detection, and this despite their challenges for dogs due to their complex mixtures of VOCs. While these substrates hold significant clinical potential, and urine being a frequently used substrate for cancer detection, they have not yet been studied for canine detection thresholds. In contrast, mineral oil is frequently used in experimental studies due to its simplicity, despite its lack of relevance for clinical applications.

Within this pilot study, we trained two dogs to investigate the canine detection threshold for a single VOC within a complex mixture. We focus on isoamyl acetate, selected for its consistency and comparability in prior studies of canine olfaction [8,13–15]. Our objectives were to define the artificial urine, including identifying the VOCs to be added and evaluating the stability of the chosen mixture, and to determine the canine detection threshold of isoamyl acetate in this artificial urine mixture, comparing the results with findings from studies using mineral oil as a solvent.

Materials and methods

Dogs

This study involved two detection dogs from the KDOG Program: Nougaro, a 7-year-old intact Labrador Retriever weighing 34 kg, and Prince, a 5-year-old intact Springer Spaniel weighing 19 kg. Both dogs had previous experience in medical detection. Both dogs were fed the same commercially available dry diet (4300 Sporting Life Energy, Royal Canin SAS, Aimargues, France).

Odor sample preparation

Literature review and selection process.

A comprehensive literature review was undertaken using PubMed and Google Scholar to identify VOCs present in human urine. The objective was to identify the most frequently detected and quantifiable VOCs using gas chromatography-mass spectrometry (GC-MS) techniques. A selection of 12 relevant publications was made for analysis, detailed in S1 Table. The focus of the literature review was on identifying VOCs consistently reported across multiple studies. This approach ensured the representation of diverse chemical families and included the most cited VOCs from the selected 12 publications. S2 Table provides comprehensive information on the compounds identified in the selected publications, including their total number of references among the 12 publications, concentrations found in human urine, corresponding references, and a brief description as well as their probable origin. Following the identification of key VOCs, a careful selection of 12 compounds was made to create an artificial urine mixture. This selection process aimed to replicate the composition of human urine while ensuring a balanced representation of the most frequently detected VOCs. List of VOCs selected to compose artificial urine: 3-hexanone; 2-heptanone; 4-heptanone; 2-pentanone; 2-butanone; p-cresol; dimethyldisulfide; furan; octanal; pyrrole; p-cymene; trimethylamine.

Preparation of artificial urine.

To achieve accurate concentrations and mimic physiological levels of VOCs found in human urine, a protocol adapted from Sarigul et al [16]. was followed. The creation of an artificial urine matrix closely resembling human urine involved two main steps. Firstly, a basic urine matrix was prepared by dissolving multiple compounds in distilled water at 37°C. The pH was adjusted to 5–6, and the sterility of the artificial urine matrix was ensured using sterile filtration units (0.2 µm, Fisherbrand polyethersulfone). Furthermore, pH levels of the basic urine matrix were monitored for 6 weeks to ensure adherence to physiological ranges commonly observed in human urine. In the second step, the 12 additional identified VOCs were added to the basic urine matrix either just before or up to a maximum of 1 week before sample usage (see S3 Table for composition and concentration). For compounds whose concentration in urine has not been determined (p-cymene; octanal; dimethyl disulfide; pyrrole), a default concentration of 5nmol/mmol creatinine was assigned. Following the addition of these l2 VOCs, stability tests were conducted to evaluate the robustness of the matrix over time, ensuring consistency and reliability in subsequent analytical procedures. An analysis was conducted using Stir Bar Sorptive Extraction (SBSE) on 1 cm length magnetic stir bars (Twisters, Gerstel) coated with polydimethylsiloxane (1 mm film thickness) and GC-ToF-MS (GC 7890B, Agilent coupled with Pegasus BT ToF-MS, LECO) to confirm the stability of the mixture. The peak area ratios, which represents the intensity ratio between a compound and an internal standard, was used to assess the stability of compounds over time. The comparison of peak area ratios between the initial analysis at T0 and the analysis at t + 7 days (expressed as a percentage) showed no variation, indicating consistent signal intensity. This suggests that the compounds remained stable, with no detectable degradation, during 7 days of storage at 4°C (S1 Fig).

Sample preparation.

The dogs were trained to detect solutions of Isoamyl acetate (or Acetic acid 3-methylbutyl ester or Isopentyl acetate, CAS 123-92-2; ≥ 99.7% Sigma Aldrich, 79857–5ml, 6.73mol/L) diluted in water or artificial urine at different concentrations. Isoamyl acetate was chosen based on previous studies testing olfactory detection thresholds in humans [17], rodents [18,19], and dogs [13,14,20] but also because of its high volatility, its distinct banana-like odor, and safety to handle. The isoamyl acetate stock solution is diluted in half-log or quarter-log in distilled water ensuring consistency in the preparation of the target odor (serial dilution). This cascade dilution involved multiple steps, with each step consisting of 5 μL of the stock solution being mixed with the appropriate volume of distilled water to achieve 10 mL of the desired concentration. The number of dilutions (ranging from 1–6) depended on the desired final concentration, with each step using the solution from the previous dilution. The first concentration presented to the dogs is 6.73 x 10-4 molar (M), during the training phase. All serial dilution steps were made in clean 15 centrifuge tubes, PET, conical bottom w/plug seal cap (Product# CLS430055, Merck). Samples were prepared in advance for a full week of work with the dogs.

Analysis of isoamyl acetate stability in aqueous medium.

To investigate the stability of isoamyl acetate in water, solutions were prepared at three concentrations (6.7 ×  10⁻6 M, 6.7 ×  10⁻7 M, and 6.7 ×  10⁻8 M). Each concentration was replicated three times at each time point for analysis.

The samples were stored at + 4°C and analyzed at three intervals: immediately after preparation (t0), after 9 days, and after 17 days. Static headspace analyses were performed with a GC-MS Q2010 Ultra purchased from Shimadzu (Kyoto, Japan). A RTX-5MS column (50 m ×  0.18 mm, 0.17 μm) (Restek, France) was used to conduct the chromatographic separation. The initial temperature was 35 °C, held for 4 min, first raised to 140 °C at 5 °C/min and then raised to 280 °C at 12.5 °C/min and held for 10 min. A mass spectrometer was used with the electronic ionization source (70 eV) heated at 200 °C. The acquisition was made with scan and SIM modes. The scan range was 30–270 m/z. The SIM window was from 12 to 12.50 minutes and the ions 43, 55, 70, and 87 were monitored. Data were acquired with GC Real Time Analysis and processed with GC PostRun Analysis 4.53 (Shimadzu software).

Analysis of isoamyl acetate stability in artificial urine.

To assess the stability of isoamyl acetate in artificial urine, solutions were prepared at three different concentrations: 6.729 ×  10⁻6 M, 6.729 ×  10⁻7 M, and 6.729 ×  10⁻8 M. Three technical duplicates were performed for each concentration at each time point. The tubes were stored at + 4°C. Samples were analysed at three time points: immediately after preparation (t0), after 9 days, and after 19 days. Solid Phase MicroExtraction (SPME) combined with GC-MS (Agilent 7890B GC,5977 MSD System) on a DB-624 semi-polar column (30 m x 0.32 mm x 1.4 µm) (Agilent) was used for analysis. A DVB/CAR/PDMS SPME fiber was employed for the sample extraction. Raw data were processed using MassHunter® Quantitative Analysis software. p-Cresol, present in the matrix at 0.2854 ×  10⁻6 M and stable in the model urine, served as the internal standard.

Training and testing procedure

Training and tests were conducted between May 2023 and July 2023 in Champvoisy, Marne, France, using two combined Algeco modular units, which are portable, prefabricated buildings used for various purposes. This setup created a controlled environment that allowed for the separation of the dog and handler from the operator (the person who knew the location of the positive sample during single-blind session). A fixed-position camera captured all sessions, and data were simultaneously uploaded to an online server for analysis.

The training was conducted by two experienced handlers. The dogs were trained using positive reinforcement methods and rewarded with toys. They were exercised five days a week, receiving twice-daily off-leash walks in groups with alongside other dogs. Dogs participated in up to two sessions per day, one conducted in the morning before lunch and another in the afternoon. The dogs had training and testing in a temperature- (average 20°C) and humidity-controlled (humidity between 40%-60%) experimental room over 5 months, working with the same handler.

During both training and testing phases, four metal cones were mounted on a support at a height of 72 cm for the Labrador Retriever and 39 cm for the Springer Spanish, enabling the dogs to insert their noses into the cones. The cones containing the detection samples are designed to enhance the diffusion of VOCs by featuring a wide and low opening (Fig 1A). Each session consisted of multiple lines, with each line comprising four different cones (Fig 1B).

Fig 1. A. A costum-made metal cone with a wide opening and space for a wide-mouth vial containing the sample. B. Example of the experimental setup for training and testing environment, with the positive sample positioned on the 4th cone.

Fig 1

In the initial training phase, cones contained either water with isoamyl acetate or water alone. Later in the experiment, in both the training and testing phases, the cones were filled with either artificial urine alone or artificial urine mixed with isoamyl acetate.

To enhance VOC diffusion, 10 mL of isoamyl acetate solution of a given concentration was placed in low, wide-mouth glass containers. Three control cones contained 10 mL of artificial urine in identical, thoroughly cleaned glass containers, with each container cleaned with water after each line. Clean water was used to remove isoamyl acetate residues between lines, as its odorless nature prevents interference, unlike alcohol/ethanol, which could affect the dogs’ reactions. At the end of the day alcohol was used to clean the cones.

Dogs were initially trained using water as a substrate with various concentrations of isoamyl acetate, and the same protocol was applied to both training with water and testing with artificial urine. The target odor location was pseudorandom such that the target odorant was not in the same location for more than three trials in a row. The experimental design was divided into two different sessions (Fig 2):

Fig 2. Experimental design of training and testing sessions.

Fig 2

A. Training session: Dogs were trained during 1–4 days with three lines of motivation of followed by a simple blinded lines with the tested concentration. When the dog successfully passes the level of concentration during testing (success in more than 75% of the lines), he was tested in a double-blind situation (B). B. Testing session: The testing session consists of three lines of motivation, two or three lines of simple blind tests, then four lines of double-blind tests. In the preliminary single-blinded phase, we required dogs to correctly complete two trials before advancing to the double-blinded phase. If a dog succeeded in only one out of the first two trials, a third trial was conducted to provide an additional opportunity for qualification.

  1. Training session (Fig 2 A): Each training session began with an evaluation of the dog’s interest. This involved three initial tests at a concentration of isoamyl acetate higher than the test concentration (C > 1/2 log (Ctest)). Subsequently, the dogs were tested with at least four test lines using the target concentration in a single-blind setup. Each line consisted of four cones, and between each line, the samples were replaced and the cones were cleaned with water.

  2. Test session (Fig 2 B): The test session consists of three lines of interest, two or three lines of simple blind tests, then four lines of double-blind tests. In the preliminary single-blinded phase, we required dogs to correctly complete two trials before advancing to the double-blinded phase. If a dog succeeded in only one out of the first two trials, a third trial was conducted to provide an additional opportunity for qualification. During the test sessions, if the dog achieved a success rate of 75% (correctly identifying the positive sample in at least 75% of the tests), the concentration was decreased by ½  log or ¼  log for subsequent training and test sessions.

If a dog failed to show adequate interest—indicated by failure in 2 or 3 of the initial interest tests—a one-hour break was implemented before a new session. If failure persisted after the break, a corrective session with a higher concentration could be conducted later the same day if signs of lack of interest were observed.

The testing protocol included both single-blind and double-blind conditions:

  • Single-Blind Tests: The handler was unaware of the location of the positive sample, the position of the positive sample is known only to the operator in the adjacent building unit. After passing the single-blind tests, dogs moved to double-blind testing. In practice, there is a window between the two units that allows the operator to communicate with the handler. This setup enables the handler to observe the operator’s cues and reward the dog correctly when it makes the right decision, or withhold rewards if the dog makes an incorrect decision.

  • Double-Blind Tests: Neither the handler nor the operator knew the location of the positive sample. These sessions included three lines for assessment of interest, followed by two or three single-blind lines and then 4 double-blind lines. Samples for both single- and double-blind sessions were prepared in the same manner, with the only difference being the level of anonymization. Samples were prepared in advance at the laboratory, and tubes for double-blind tests were anonymized. During double-blind sessions, the dog was always rewarded.

It is crucial to recognize that biases can arise if someone involved knows the results, as dogs are highly sensitive to subtle cues. To address this, meticulous precautions were taken to minimize unintentional signaling and maintain the integrity of the testing conditions.

The dogs were trained, with a clicker, to sit in front of the cone containing the isoamyl acetate sample and wait for a reward (a toy). In case of an incorrect indication, the dog was not rewarded. In double-blind situations, dogs were rewarded for each indication since the handler was unaware of the positive sample’s location.

The detection threshold for each dog was determined when the success rate dropped below 75% (Fig 3). In case of failure, another double-blind session (4 lines) is tested after a corrective session with a higher concentration. The maximum amount of trials was a maximum of 4 with each trial (=line) consisting of 4 cones.

Fig 3. Performance of two dogs relative to concentration levels.

Fig 3

On the y-axis are the performances of the dogs in %, by concentration. The concentrations are indicated on the x-axis The success threshold is set at 75%.

Weather data analysis

The potential impact of weather conditions on the results was analyzed using the meteorological data from two nearby weather stations provided by Météo France (https://meteo.data.gouv.fr/datasets/donnees-climatologiques-de-base-horaires/). The stations, Chambrercy (station number 51111001) and Igny-Comblizy (station number 51298001) are located within 20 kilometers of the test site in Champvoisy, France (department 51).

Due to the unavailability of weather data for the Chambrercy station for the year 2023, the data from the Igny-Comblizy station were used. The data were segmented into hourly intervals, with these one-hour periods selected as the most appropriate for analysis. The analysis specifically examined variables of temperature and precipitation.

Canine behaviour

A list of behaviors assessed by video.was developed to ethically assess some stress behaviours of dogs during tests, based on a previous publication [21] (S4 Table). Behaviors were coded from video recordings using the software Boris [22] (version 8.27 – Università di Torino). Additionally, a simpler observation of the dogs’ behaviours was coded by two independent experimenters, following the criteria outlined in Table 1. We attempted to observe which paws were lifted; however, the camera position did not allow for sufficient precision. We only have accurate information for the first two paws. The objective of these observations was to assess the dog’s emotional state.

Table 1. Coding scheme for behaviours associated with marking.

Dogs’ behaviour Definition
Correct search The dog did everything in the way it was expected to do.
Indecision The dog hesitates or performs a partial mark (lowers its hindquarters but quickly raises them again) on one or more cones.
No selection The dog sniffed several cones but does not signalling any cone on its own.
Do not search The dog does not seem to sniff the cones or repeatedly looks at the handler during the run.
Sweep The dog inspected cone x + 1 and then returned to inspect the previous cone x. This behaviour was noted for further analysis.
Look The dog looked at the handler before indicating.

Statistical analysis

Qualitative data are expressed as numbers and percentages [n (%)] and quantitative data as median (interquartile range [IQR]). Data were compared using Pearson’s chi-square test or Fisher exact test. To determine the optimal session duration that maximizes the success rate, we utilized a Receiver Operating Characteristic (ROC) analysis. We then plotted the ROC curve by calculating the true positive rate (sensitivity) and the false positive rate (1 - specificity) for different duration thresholds. In this context, sensitivity refers to the ability of the trained dogs to correctly identify the presence of the target VOC in the complex mixture (true positive rate), while specificity refers to the ability of the dogs to correctly identify the absence of the target VOC (true negative rate). These measures help assess the accuracy of the dogs’ detection performance. The Area Under the Curve (AUC) was computed to assess the model’s discriminative capability. The optimal threshold was determined using the Youden Index, defined as J = Sensitivity+Specificity − 1, to maximize the sensitivity and specificity values. All tests were two-tailed and P <  0.05 were considered statistically significant. Analyses were performed with STATA v17.0 (StataCorp, College Station, TX, USA).

Ethical approval

The two handlers strictly followed ethical guidelines under the supervision of a veterinarian from the French National Veterinary School of Alfort (CG). The dogs used in the study were privately owned and regularly monitored by veterinarians to ensure their health and well-being. The environment met all welfare standards, and the study was approved by the ethical committee of Royal Canin, the study’s sponsor. Data and video recordings were used with the handlers’ consent, and no biological samples from either dogs or humans were collected during the procedure.

Results

Artificial urine preparation

An artificial urine matrix was successfully developed to replicate physiological levels of VOCs in human urine. To minimize bias, pseudorandomized target locations were employed for sample presentation, and all samples were pre-prepared in the laboratory to ensure consistency throughout the training sessions. Over a six-week monitoring period, pH levels were confirmed to be maintained within physiological ranges (data not shown).

Analysis of isoamyl acetate stability in squeous medium

In water, isoamyl acetate signals decreased on average by approximately 84% after 9 days with complete degradation observed after 17 days at 4°C for the highest concentration (see S2 Fig).

Analysis of isoamyl acetate stability in artificial urine

In artificial urine, isoamyl acetate signals decreased on average by approximately 25% after 9 days and 37% after 19 days of storage at 4°C, with p-cresol serving as a stable internal standard throughout the analysis (see S3 Fig).

Description of tests

A total of 76 sessions were conducted by the 2 dogs, with a mean duration of 24 minutes (range: 19–28 minutes). In total (including interest, simple-blinded tests, and double-blinded tests), 597 lines were performed, with 407/579 (68.2%) lines being positively marked and 52/65 (80%) during the double-blinded tests. Regarding the dogs’ behaviour, 19 lines (3.2%) were not marked by the dogs, and the dogs appeared indecisive in 49 (8.2%) the lines. One dog exhibited slightly higher performance, succeeding in 6 out of 7 sessions during the double-blind test, compared to 7 out of 9 sessions for the second dog. The mean age of the samples was 6.5 days (range: 3.5–7 days) for the double-blind test, compared to 6 days (range: 5–7 days) for the overall sessions (Table 2).

Table 2. General overview of the results, including the total number of trials and double-blinded conditions. Results are presented as absolute values, with square brackets indicating the range (minimum to maximum) and percentages shown in parentheses.

TOTAL LINES
 Number of dogs 2
 Number of sessions 76
 Duration of session (min) (n = 76) 24 [19–28]
 Age of the sample (days) (n = 76) 6 [5–7]
 Number of cones 2388
 Number of lines 597
 Number of positives lines marked (n = 597) 407 (68.2)
 Behaviour of the dog per line (n = 597)
 No comment 511 (85.6)
 Indecision 49 (8.2)
 No selection 19 (3.2)
 Does not search 18 (3.0)
DOUBLE-BLIND LIN ES
 Number of sessions 16
 Number of successful sessions (n = 16) 13 (81.3)
 Number of successful sessions NOUGARO (n = 9) 7 (77.8)
 Number of successful sessions PRINCE (n = 7) 6 (85.7)
 Age of the sample (days) (n = 16) 6.5 [3.5–7]
 Number of cones 260
 Number of lines 65
 Number of positive lines marked (n = 65) 52 (80.0)
 Behaviour of the dog per line (n = 65)
 No specific observation 63 (97.0)
 Indecision 1 (1.5)
 No selection 1 (1.5)
 Does not search 0 (0)

Dogs’ detection threshold of amyl acetate in artificial urine

The lowest olfactory threshold for isoamyl acetate achieved was 6.7 ×  10⁻9 M in artificial urine for Nougaro (Labrador Retriever) and 2.1 ×  10⁻7 M for Prince (Springer Spaniel) (only the tests in double-blinded conditions were used for this analysis). Water was used solely for training the dogs to detect isoamyl acetate odor.

Influence of sample age on performance

In the double-blind data, the dogs’ behavior (p = 0.549) nor performance (p = 0.1) was influenced by the age of the sample (Table 3)

Table 3. Dogs’ behaviour and performance linked to sample age during double-blinded tests. Percentages are shown in parenthesis.

<5 days [5–7[days ≥7 days p
Behaviour of the dog
No specific behaviour linked to decision
20/20 (100) 16/17 (94.1) 27/28 (96.4) 0.549
Indecision 0 (0) 0 (0) 1/28 (3.6)
No selection 0 (0) 1/17 (5.9) 0 (0)
Performance
Success 3/4 (75) 2/4 (50) 8/8 (100) 0.100

Performance in double-blinded tests

Dogs marked the first cone in the line more frequently (p =  0.049, Table 4), despite the position of the positive cone being correctly randomized during double-blind tests (p =  0.72, data not shown). None of the behaviors observed using the ethogram-like table (S4 Table) were linked to performance in double-blind tests (data not shown).

Table 4. Description of position of negative marked samples in urine, in double-blinded settings. Percentages are shown in parenthesis.

Position 1 n = 65 Position 2 n = 65 Position 3 n = 65 Position 4 n = 64 p
Cones with negative samples that were marked by the dogs 6 (9.2) 4 (6.2) 2 (3.1) 0 (0) 0.049

Behavior observations in single-blind tests

In single-blind tests, dogs looked at the handler less frequently after marking when they successfully identified the correct sample, underscoring the importance of focusing on the dogs’ behavior during tests (p =  0.008, data not shown). Sweeping behavior did not affect the performance of the dogs (p =  1, data not shown).

Impact of weather conditions

The potential impact of weather conditions on the results was assessed using meteorological data from the Igny-Comblizy weather station, as data from the Chambrercy station were unavailable for 2023. Hourly temperature and precipitation data were analyzed, revealing no significant seasonal variations or external temperature fluctuations that affected the dogs’ detection abilities (data not shown). Since the dogs are from outdoors and often play outside between sessions, we measured all factors, including weather, to account for potential influences on their behavior and ability to detect VOCs. Additionally, we wanted to verify that the Algeco modular units were suitable for this type of setup.

Discussion

This study evaluates dogs’ ability to detect isoamyl acetate in a urine-like mixture, showing they can reliably identify it in the complex medium at very low concentrations (6.7 × 10⁻9 molar – 6.7 parts per billions). Detection becomes more challenging as concentrations decrease. A previous study on isoamyl acetate in mineral oil found a detection threshold between 40 ppb to 1.5 ppt, with significant inter-dog variability [8]. Our findings align with this, but our study set a higher success threshold at 75%, compared to the 40% threshold used by Concha et al. [8]. Dogs’ detection threshold for isoamyl acetate in both artificial urine and mineral oil is at the ppb level, highlighting their exceptional sensitivity and potential in high-sensitivity medical tasks.

Initial instability in water led us to test it in urine, where it proved more stable. Aging of amyl acetate did not affect detection ability, but chemical stability must be rigorously analysed in future VOC studies to avoid unreliable results.

To ensure reliable results and minimize bias, both single-blind and double-blind protocols were used. The behaviour differences in the two dogs during single-blind and double-blind tests highlights the importance of these setups. Previous studies [23,24] have shown that handler knowledge affects team performance and dogs’ behaviour. In single-blind setups, the operator, aware of the target odor location, was isolated to prevent interaction with the dog, minimizing unintended cues. However, the handlers’ knowledge in single-blind protocols could still influence the dog’s behavior. Double-blind protocols eliminated potential biases from handlers [24], reinforcing the study’s integrity. Future studies should implement the training method recommended by Edwards et al. (2017) [25], where the operator with sample status information is positioned outside the room and uses a numerical screen to communicate with the trainer. This approach would help avoid reinforcing false indications for disease-negative samples, as observed in this study, and strengthen the validity of the findings.

This study highlights performance differences between the two dogs, reflecting olfactory capacities influenced by factors such as genetics [9,26], trainability [27], age [28], breed [29], medications [30], and microbiome composition11. These differences emphasize the need for standardized methodologies in canine medical detection and a larger number of dogs to better understand the factors that influence outcomes.

Throughout the study, the dogs exhibited minimal stress, though camera positioning may have affected behavioural assessments. The two dogs involved in this protocol showed no behavioural issues, but more anxious dogs may take longer to solve tasks and exhibit stress-related behaviours [31], highlighting the importance of assessing a dog’s temperament before selecting it for detection tasks [32].

Developing a reliable canine working protocol is essential for establishing detection thresholds, as many dogs are excluded during training, especially when detecting low-concentration biomarkers for diseases like cancer. Using artificial mixtures in selection protocols could help screen dogs without depleting valuable biological samples. Due to our small size (only two dogs), we could not validate this protocol. Future studies should include a larger, more diverse dog cohort, test across various diseases and matrices, and include medically relevant odors to refine and validate the protocol for real-world medical detection applications.

We conducted the study in a mobile environment with two interconnected modular units, offering flexibility in relocating the unit as needed and particularly beneficial in resource-constrained countries. We maintained strict control over temperature and humidity levels within the unit. Our findings indicated that seasonal variations and external temperature fluctuations did not impact the dogs’ detection abilities within this mobile setup, aligning with results from previous studies [28,33].

The spatial organization of odour cones impacted detection accuracy, with dogs consistently marking samples within the first cone. While target odor positions were randomized, complete randomization can reinforce positional bias if the dog favours a particular location. Personalized randomization could help adapt to each dog’s tendencies [34]. A circular setup (carousel) [8] has been proposed to enhance detection reliability by allowing dogs to revisit samples. Optimizing cone organization could improve canine detection accuracy in practical applications.

In conclusion, our study confirms the remarkable ability of dogs to detect amyl acetate in complex mixtures within a mobile and controlled environment. These findings align with prior studies on the exceptional sensitivy of canine olfaction, even in challenging conditions. Notably, this is the first pilot study to explore a dog’s ability to detect a single VOC in a complex medium like artificial urine, advancing research into canine medical detection. Despite variability between the two dogs tested, our findings showcase the unique capabilities of canine olfaction and its potential to complement non-invasive diagnostic tools in medical research.

Supporting information

S1 Table. Publications for selection of key volatile organic compounds in human urine.

(XLSX)

pone.0321394.s001.xlsx (10.4KB, xlsx)
S2 Table. Identified VOCs in a literature search of 12 relevant publications with their total number of references, chemical family, found concentration, and short description.

(XLSX)

pone.0321394.s002.xlsx (22KB, xlsx)
S3 Table. Composition of artificial urine.

(XLSX)

pone.0321394.s003.xlsx (10.3KB, xlsx)
S4 Table. List of behaviors assessed by video.

(XLSX)

pone.0321394.s004.xlsx (10.1KB, xlsx)
S1 Fig. Bar charts showing the relative intensities of GC-MS peak areas of VOCs in the model urine matrix at the initial time (“t0”) and after 7 days of storage at 4°C (“t0 + 7 days”). The peak areas at the initial time (“t0”) are expressed as 100% reference values (blue bars). The “Ratio t0 + 7 days/t0” (red bars) indicates the percentage ratio of values obtained after 7 days of storage to the initial values. Error bars represent the average standard deviation (n = 3).

(TIF)

pone.0321394.s005.TIF (4.4MB, TIF)
S2 Fig. Stability of amyl-acetate in water. The boxplot displays the interquartile range, with the central line representing the median. The whiskers extend to the range of the data (1.5 IQR from the quartiles), and the diamond-shaped dots indicate outliers. The missing part of the boxplot corresponds to 0 values, which are not visible due to the log scale used in the plot. The Y-axis represents the area under the curve refers to the integrated signal corresponding to a specific compound or ion as it elutes through the chromatographic column. This area is used to quantify the amount of a particular substance in the sample. The X-axis represents the theoretical concentration of Isoamyl Acetate in water.

(TIF)

S3 Fig. Stability of amyl-acetate in artificial urine. The boxplot displays the interquartile range, with the central line representing the median. The whiskers extend to the range of the data (1.5 IQR from the quartiles), and the diamond-shaped dots indicate outliers. The missing part of the boxplot corresponds to 0 values, which are not visible due to the log scale used in the plot. The Y-axis represents the relative response in GC-MS, which is the intensity of the analyte signal relative to the total ion current or to an internal standard, allowing for comparison across different concentrations and conditions. The X-axis represents the theoretical concentration of Isoamyl Acetate in urine.

(TIF)

pone.0321394.s007.TIF (4.7MB, TIF)

Acknowledgments

The authors wish to thank the Royal Canin Foundation, Handi’Chiens, Didier Valentin, Florian Conchaudon, Philippe Mont, Camille Alahdef, Elyes Hadjsaid and Hind Baba Aissa for their support and assistance with this project.

Data Availability

The dataset and its corresponding data dictionary are publicly available on Figshare at https://figshare.com/s/d128cd03724e5be874ee.

Funding Statement

This study was funded by the Royal Canin Foundation and a sponsorship from Seris Security. The funders had no role in the study design, data collection, analysis, or interpretation of the results.

References

  • 1.World Health Organization. Cancer. 2022. https://www.who.int/news-room/fact-sheets/detail/cancer [Google Scholar]
  • 2.Jendrny P, Twele F, Meller S, Osterhaus ADME, Schalke E, Volk HA. Canine olfactory detection and its relevance to medical detection. BMC Infect Dis. 2021;21(1):838. doi: 10.1186/s12879-021-06523-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jezierski T, Walczak M, Ligor T, Rudnicka J, Buszewski B. Study of the art: canine olfaction used for cancer detection on the basis of breath odour. Perspectives and limitations. J Breath Res. 2015;9(2):027001. doi: 10.1088/1752-7155/9/2/027001 [DOI] [PubMed] [Google Scholar]
  • 4.Moser E, McCulloch M. Canine scent detection of human cancers: a review of methods and accuracy. J Vety Behav. 2010;5:145–52. [Google Scholar]
  • 5.Bauër P, Leemans Michelle, Audureau E, Fromantin I. Remote medical scent detection of cancer and infectious diseases with dogs and rats: a systematic review. 1–38;2021. [DOI] [PMC free article] [PubMed]
  • 6.Leemans M, Bauër P, Cuzuel V, Audureau E, Fromantin I. Volatile organic compounds analysis as a potential novel screening tool for breast cancer: a systematic review. Biomark Insights. 2022;17:11772719221100709. doi: 10.1177/11772719221100709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Angle C, Waggoner L. P, Ferrando A, Haney P., Passler T. Canine detection of the volatilome: a review of implications for pathogen and disease detection. Front. Vet. Sci. 3, (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Concha AR, Guest CM, Harris R, Pike TW, Feugier A, Zulch H. et al. Canine olfactory thresholds to amyl acetate in a biomedical detection scenario. Front. Vet. Sci. 5, (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sacharczuk M, Walczak M, Adamkiewicz E, Walasek A, Ensminger J, Presch M, et al. Polymorphism of olfactory and neurotransmitters receptor genes in drug and explosives detection dogs can be associated with differences in detection performance. Appl Anim Behav Sci. 2019;215:52–60. [Google Scholar]
  • 10.Kokocińska-Kusiak A, Woszczyło M, Zybala M, Maciocha J, Barłowska K, Dzięcioł M. Canine olfaction: physiology, behavior, and possibilities for practical applications. Animals (Basel). 2021;11(8):2463. doi: 10.3390/ani11082463 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jenkins EK, DeChant MT, Perry EB. When the nose doesn’t know: canine olfactory function associated with health, management, and potential links to microbiota. Front vet sci. 2018;5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Naudon L, François A, Mariadassou M, Monnoye M, Philippe C, Bruneau A, et al. First step of odorant detection in the olfactory epithelium and olfactory preferences differ according to the microbiota profile in mice. Behav Brain Res. 2020;384:112549. doi: 10.1016/j.bbr.2020.112549 [DOI] [PubMed] [Google Scholar]
  • 13.Krestel D, Passe D, Smith JC, Jonsson L. Behavioral determination of olfactory thresholds to amyl acetate in dogs. Neurosci Biobehav Rev. 1984;8(2):169–74. doi: 10.1016/0149-7634(84)90037-x [DOI] [PubMed] [Google Scholar]
  • 14.Walker DB. Naturalistic quantification of canine olfactory sensitivity. Appl Anim Behav Sci. 2006;97:241–54. [Google Scholar]
  • 15.DeChant MT, Hall NJ. Training with varying odor concentrations: implications for odor detection thresholds in canines. Anim Cogn. 2021;24(4):889–96. doi: 10.1007/s10071-021-01484-6 [DOI] [PubMed] [Google Scholar]
  • 16.Sarigul N, Korkmaz F, Kurultak İ. A New artificial urine protocol to better imitate human urine. Sci Rep. 2019;9(1):20159. doi: 10.1038/s41598-019-56693-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Walker JC, Hall SB, Walker DB, Kendal-Reed MS, Hood AF, Niu X-F. Human odor detectability: New methodology used to determine threshold and variation. Chem Senses. 2003;28(9):817–26. doi: 10.1093/chemse/bjg075 [DOI] [PubMed] [Google Scholar]
  • 18.Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet M-F. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci. 2008;28(2):247–56. doi: 10.1111/j.1460-9568.2008.06346.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mandairon N, Stack C, Kiselycznyk C, Linster C. Enrichment to odors improves olfactory discrimination in adult rats. Behav Neurosci. 2006;120(1):173–9. doi: 10.1037/0735-7044.120.1.173 [DOI] [PubMed] [Google Scholar]
  • 20.Hirano Y, Oosawa T, Tonosaki K. Electroencephalographic olfactometry (EEGO) analysis of odour responses in dogs. Res Vet Sci. 2000;69(3):263–5. doi: 10.1053/rvsc.2000.0420 [DOI] [PubMed] [Google Scholar]
  • 21.Bryant DA, Dunham AE, Overall KL. Roles for referential focus in effective and efficient canine signaling: do pet and working dogs differ?. J Vet Behav. 2018;27:55–66. doi: 10.1016/j.jveb.2018.07.005 [DOI] [Google Scholar]
  • 22.Friard O, Gamba M. BORIS: a free, versatile open‐source event‐logging software for video/audio coding and live observations. Methods Ecol Evol. 2016;7(11):1325–30. doi: 10.1111/2041-210x.12584 [DOI] [Google Scholar]
  • 23.Lit L, Schweitzer JB, Oberbauer AM. Handler beliefs affect scent detection dog outcomes. Anim Cogn. 2011;14(3):387–94. doi: 10.1007/s10071-010-0373-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.DeChant MT, Ford C, Hall NJ. Effect of handler knowledge of the detection task on canine search behavior and performance. Front Vet Sci. 2020;7. doi: XX [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Edwards TL, Browne CM, Schoon A, Cox C, Poling A. Animal olfactory detection of human diseases: guidelines and systematic review. J Vet Behav. 2017;20:59–73. [Google Scholar]
  • 26.Lesniak A, Walczak M, Jezierski T, Sacharczuk M, Gawkowski M, Jaszczak K. Canine olfactory receptor gene polymorphism and its relation to odor detection performance by sniffer dogs. J Hered. 2008;99(5):518–27. doi: 10.1093/jhered/esn057 [DOI] [PubMed] [Google Scholar]
  • 27.Dalal S, Hall NJ. Behavioral persistence is associated with poorer olfactory discrimination learning in domestic dogs. Behav Processes. 2019;162:64–71. doi: 10.1016/j.beproc.2019.01.010 [DOI] [PubMed] [Google Scholar]
  • 28.Salamon A, Baranya E, Zsiros LR, Miklósi Á, Csepregi M, Kubinyi E, et al. Success in the natural detection task is influenced by only a few factors generally believed to affect dogs’ olfactory performance. Sci Rep. 2024;14(1):12351. doi: 10.1038/s41598-024-62957-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Polgár Z, Kinnunen M, Újváry D, Miklósi Á, Gácsi M. A test of canine olfactory capacity: comparing various dog breeds and wolves in a natural detection task. PLoS One. 2016;11(5):e0154087. doi: 10.1371/journal.pone.0154087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jenkins EK, Lee-Fowler TM, Angle TC, Behrend EN, Moore GE. Effects of oral administration of metronidazole and doxycycline on olfactory capabilities of explosives detection dogs. Am J Vet Res. 2016;77(10):906–12. [DOI] [PubMed] [Google Scholar]
  • 31.Passalacqua C, Marshall-Pescini S, Merola I, Palestrini C, Previde EP. Different problem-solving strategies in dogs diagnosed with anxiety-related disorders and control dogs in an unsolvable task paradigm. Appl Anim Behav Sci. 2013;147:139–48. doi: 10.1016/j.applanim.2013.06.002 [DOI] [Google Scholar]
  • 32.Miller SL. The importance of evaluating positive welfare characteristics and temperament in working therapy dogs. Front Vet Sci. 2022;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wohlfahrt G, Author2 F, Author3 F. Air temperature and humidity effects on the performance of conservation detection dogs. Appl Anim Behav Sci. 2023;262:105909. [Google Scholar]
  • 34.Lazarowski L, Krichbaum S, DeGreeff LE, Simon A, Singletary M, Angle C, et al. Methodological considerations in canine olfactory detection research. Front. Vet. Sci. 7, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Etsuro Ito

13 Dec 2024

PONE-D-24-48244Exploring canine’s olfactive threshold in artificial urine for medical detectionPLOS ONE

Dear Dr. Leemans,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The methods should be improved according to the reviewers' comments.

Please submit your revised manuscript by Jan 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Etsuro Ito, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form, you indicated that [Data supporting the findings of this study are available from the corresponding author upon reasonable request.].

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: We need more data papers on working dogs and this very small - really a pilot study - can be a part of those data. The paper needs some work.

Lines 125 – 126 – Please take out ‘being the first’ – you have 2 dogs with widely different performances – you an say nothing about generality. Just say “We trained 2 dogs….et cetera…”. Really, this should more appropriately be called a pilot study.

Lines 138-139 This is an inadequate description of their training – be specific.

Line 142 I don’t know what the KDOG centre is and most readers will not either

Line 239 “Motivation” is likely the wrong word here – you were assessing a dog’s interest (and many detection dog guidelines make this clear) the compound. There are a number of criteria used to evaluate motivation and you meet none of them. Please change wording throughout.

Line 271, 274 et cetera – ‘Frustration’ is another one of those words that is overly used and seldom defined. You did not reward them each time to decrease ‘frustration’ – however you define this. You did so because when you cannot know if the compound is there (eg, accelerants) you use a continuous reward schedule. You used this for 2 reasons: because you could not know in that phase (and this is why training where someone tells you in a double blind that you were correct is so critical – something that was apparently not done here and I cannot fathom why not) AND you were rewarding the dogs for working – for making a choice. You may want to read and cite some of the work of Adee Schoon on methodology for detection dogs.

Line 291 – These authors did not create this ethogram to assess stress. Instead, this was an exhaustive ethogram of behaviors exhibited under a set of 3 request conditions. Working dogs dropped many of these out compared to pet dogs. Please correct the wording.

Line 300 – Why don’t you define sensitivity and specificity first. Many people get it wrong.

Line 332 – Again – remove motivation and use ‘interest’.

Lines 349-350 – It’s not statistically significant. STOP HERE. You have 2 dogs. It’s not biologically meaningful to them or any subject who would hope to benefit from their efforts.

Lines 383+ - I am a big fan of a good literature review – but you had 2 dogs. You can talk about what other authors have opined but there is no relevance of any of this here to you with 2 dogs.

Lines 385 + - Your observed differences highlight the need for an adequate sample size.

Lines 404+ - Here’s where commentary by Schoon and Jezierski could really help you.

Line 415 – Circular set up ref??

Lines 435 + - This a very lengthy discussion for what is essentially a pilot study – you do not need most of this opinion about protocols et cetera. Condense all of this to the essentials.

Also - please check that formatting and language are correct throughout for an English language journal. For example - quotes should be on "top".

Reviewer #2: General comments:

This study examined two dogs' olfactory detection threshold for isoamyl acetate, which have been studied earlier. However, the authors created a more practical/lifelike situation by creating a stable artificial urine solution (which is a great achievement) and tested to what extent these two detection dogs were able to identify the isoamyl acetate in it.

However, there is one major problem with the study. There is no difference between the single-blind and double-blind conditions. The authors stated that in single-blind tests: “The handler was unaware of the location of the positive sample, the position of the positive sample is known only to the operator in the adjacent building unit.” Then they state in the discussion: “In a single-blind situation, the handler, being blind, is the one who can provide clues that may subtly affect the dog's behavior. Double-blind protocols, while more complex to execute, provided additional assurance by eliminating potential biases from human handlers, thereby reinforcing the study's methodological integrity.”

In single-blind protocols only the operator knows the location of the target, but the operator is present in the test location (See Script 3 of Experiment 2 (page 3) in DeChant et al. (2020)! In this case the operator or the dog may be able to read subtle cues from the operator (not the handler who has no idea about the target location!) about the location of the target scent.

In double-blind protocols, neither the handler, nor the operator knows the location of the target scent, so the dog or the handler would not be able to read subtle cues about the location of the target from the operator. So by eliminating the presence of the operator next to the line-up during the single-blind protocol, the authors effectively made the situation double-blind.

Based on this the paper needs a major rewrite, in a way that the single-blind tests are either left out or merged with the double-blind test data and then a reanalysis is also needed.

Apart from the above, the introduction and discussion are relatively well written, but the methods and results need clarifications. The tables and graphs also need further clarifications.

Other specific comments:

L78: olfactory threshold OF dogs

L81-83: This should be rephrased as it sounds that the dogs were separately trained to indicate each different concentration of isoamyl acetate. However, I presume the dogs were trained to indicate the presence of isoamyl acetate.

L83: “consistent handlers” – consistent in what way?

L84-85: “During double-blinded tests, handlers were unaware of the target’s position.” – this is common knowledge, so it can be deleted

L86: “Be consistent in the use of comma or dots for decimals. Use the one required by the journal.”; Do the dogs not have an ID number or names? Why are they just called one dog and the other?

L109-111: This is all true, however, it is important to bear in mind that a dog can work a couple of hours before it needs to rest. The amount of dogs that would be necessary for a cancer screening programme can be enormous. Covid detection dogs had the same hype, and this was one of the reasons, why they were not utilized in large scale, whether it be hospitals or public places.

L126: What is the relevance of isoamyl acetate from a medical point of view? Why did not the authors use some molecule that is medically relevant for cancer detection? What is the reason why many other studies used isoamyl acetate for olfactory detection threshold?

L131-132: This last sentence would fit more in the conclusion and not in the aim of the study.

L137: “were intact” – is already mentioned in the previous sentence

L139-140: “They were exercised five days a week, receiving twice-daily off-leash walks in groups with other dogs and training sessions.” – This sentence is confusing, should be rephrased. Clarify how many training sessions and walks were done daily.

L141: delete comma before “4300”

L142: duplicate bracket

L143: what was the temperature and humidity setting in the experimental room?

L143-144: “working with the same handler.” – It is mentioned above that the training was conducted by two experimenters, so please clarify.

L162: Dot is missing from the end of the sentence. Why is the Furan spelled with a capital F, while the other compounds are not?

L166: The year should be deleted.

L181: What is peak area ratio?

L189: Keep it consistent, and use isoamyl acetate throughout the text to avoid confusion, if isoamyl acetate and isopentyl acetate are the same.

L193-195: If we take 5 microliter of stock solution and mix it with distilled water to achieve 10 ml of the desired solution, then that is only one concentration. It would be good to at least mention how many dilution steps were done.

L197: there should be a multiplication sign here instead of a dot

L199-200: at this point the reader does not even know what is the experimental setup, so this sentence is a but out of context here

L219: why was the last time point different in the artificial urine compared to water?

L226: delete “in 2023”, it is mentioned after that twice

L227: what is an Algeco modular unit?

L236: there is no Figure 1C

L243-244: How did the authors ensure that the clean water (relatively odorless) removed every residue of the isoamyl acetate solution (target scent) from the container?

L250-251: If there were four cones and at least six trials, how did the trainers ensured that the dogs will not favor one cone for another? E.g. in case of six trials the target scent could have been in cone no 1 and 2 twice, and in cone no 3 and 4 only once, which could have increased for preference for cones no 1 and 2 in the line-up.

L254-256: how many trials were allowed at each concentration level to reach pass the criterion?

L267: Dogs could only achieve 75% success in single blind tests (2 or 3 trials), if they were correct in all trials. Right?

L271: dog WAS always rewarded

L279-288: What was the reason for the weather data analysis? Based on L230, I thought the tests were done indoors in a temperature and humidity controlled room.

L292: citation is missing for BORIS (Friard and Gamba, 2016)

L305: there is an extra “s” at the end of the sentence

L311: Is there an approval number?

L315-321: The preparation of the artificial urine is already described in the methods.

L323-325: Any numbers or statistics about the significant decrease would be appreciated here.

L326-329: Any statistical info would be appreciated here.

L332-335: It would be easier for the reader if the results would be reported consistently in the text (either all % in brackets, or all lines in brackets).

L340-342: I don't understand this sentence. According to the methods, there were 3 dilutions used: 6.729 × 10⁻⁶ M, 6.729 × 10⁻⁷ M, and 6.729 × 10⁻⁸ M. So how could the yielded threshold be anything else for the two dogs?

L344-345: at least a p value or some numbers would be appreciated here

L347: “Dogs marked the first cone in the line more frequently” – I don't really see this from Table 4, but what I see is that the dogs were allowed to go through the line-up only once, as they were quite likely to signal at the last cone.

L348-349: This table is about sweeping, and the p value does not match in the text and the table.

L352: “data not show” – Table 3 seems to contain such information?

L353-358: The impact of weather conditions is already mentioned in the methods. I don't even know what is the point of this part, if the tests were done indoors.

L370-371: why is that study less stringent, than the current study? the same principles were used to find the detection threshold by lowering the concentration of the target odor

L411-412: “with a selection of the bowl directly in front of the experimenter” – I would remove this statement, as the experimenter was not standing next to the bowl in this study; that part is not in accordance with the results. The operator was isolated in a separate part of the unit.

L451-453: I would also add "conducting tests with medically more relevant odors".

L499: Table 1:

Wouldn't it be better to call the “No comment” the “correct search”, when the dog did everything in the way it was expected to do?

No selection: I would suggest using “dog sniffing” instead of “dog tested”, also “marking” is when a dog urinates on something therefore I would change that to “signalling”. “this comment does not apply” – This is a bit confusing remark here. The non-selection does not apply?

Sweep: So this was not allowed? The dogs had to signal on the first occasion in the correct cone?

L500: Table2: Be a bit more specific in the table caption, at least mention that the results of all the lines and the double-blind lines, and also stat what is in the brackets.

L501: Table 3: Based on the table caption, I would say this table is redundant, and the p values could be added to the text. However, if the authors wanted to show how the age of the samples affected the dogs' behavior and performance, then they should state it in the table caption. Further, state what is in the brackets.

L508: Table 5: What is the point of this table? It could be easily described in one sentence in the text.

L520: Figure 1A: Based on this picture, the reader might think that the target scent was always located in the last in the line-up. More description is needed here. Further, it is confusing to see isopentyl acetate when the authors mention isoamyl acetate almost everywhere in the text. If isoamyl acetate and isopentyl acetate are the same (or can be used as synonyms) then the authors should stick to one of them to avoid confusion.

L522: Figure 2: What makes the third single-blind test optional?

L523: Figure 3: The text is tiny on this figure, it is barley readable.

L546: missing journal name and issue number

L551, L554, L562, L601, L605, L610: missing page numbers or article number

Supplementary Table 2: What is BDD? Is the total number of references relate to the Supplementary Table 1? Is the urine concentration range created from the lowest and highest concentration reported, or the lowest and highest reported average? In several rows in the compound name does not match the name mentioned in the description. In several descriptions it seems the beginning of the description is missing, or it begins with a half sentence, or the compound name is missing.

Supplementary Table 3: In Supplementary Table 2 dots were used as decimals, while here it is a comma. Please make it consistent.

Supplementary Table 4:

Panting: OPEN mouths

Is the conductor the operator?

Avoiding physical contact: who is the someone who would touch the dog during testing?

Lowering head: lowering to what extent, how much?

Barking, whipper, backwards ears, lifts the leg while sniffing: event instead of even; lifts which leg? Why is it important?

Play with the handler: what is real play mean? Is there unreal play interaction too? what did they do for playing?

Supplementary Table 5: There is no need for this table. The information is so little that it could be just written in the text.

Supplementary Figure 1: Where is the figure caption? What do we see on the figure? What is peak area ratio, what is TO, what do the whiskers show?

Supplementary Figure 2: Where is the figure caption? What do the boxplots show (lines, whiskers, diamonds shaped dots)? Where is the rest of the green boxplot, or is the bottom of it is 0? What is the measure of the area, squared meter, squared centimeter etc.? Theoretical concentration of what (x axis description)?

Supplementary Figure 3: Same problem, as with Supplementary Figure 2

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 May 2;20(5):e0321394. doi: 10.1371/journal.pone.0321394.r003

Author response to Decision Letter 1


19 Feb 2025

Dear,

Thank you for the constructive comments and suggestions. We have revised the manuscript in accordance with the reviewers' recommendations. Below, you will find our detailed responses to each comment. Additionally, we have attached an updated version of the manuscript with track changes highlighting the modifications made in response to each reviewer’s feedback.

Kind regards,

Michelle Leemans

Attachment

Submitted filename: Response_to_reviewers_P3.docx

pone.0321394.s009.docx (50.7KB, docx)

Decision Letter 1

Etsuro Ito

5 Mar 2025

Exploring canine’s olfactive threshold in artificial urine for medical detection

PONE-D-24-48244R1

Dear Dr. Leemans,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Etsuro Ito, Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: General comments:

The authors addressed all my comments, so I am happy with the manuscript.

Few specific comments:

L88: delete “one dog”

L265: replace “Spanish” with “Spaniel” – Springer SPANIEL

L346-347: It is still unclear what is the connection between dogs' emotional state and lifting their paws?

L541: A more up to date study from that group about effects of breed (instead of Polgár et al. 2016) is this: Salamon et al. 2025 (https://doi.org/10.1038/s41598-025-87136-y), which also shows that the personality of the dog also affects olfaction.

L572: on the exceptional SENSITIVITY

L637: CUSTOM-made metal cone

L722: Jenkins reference does not have page/article number. Front Vet Sci, 5, ... (2018).

L751: DeChant reference does not have page/article number. Front Vet Sci, 7, ... (2020).

L781: Lazarowski reference does not have page/article number. Front Vet Sci, 7, ... (2020).

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: No

**********

Acceptance letter

Etsuro Ito

PONE-D-24-48244R1

PLOS ONE

Dear Dr. Leemans,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Etsuro Ito

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Publications for selection of key volatile organic compounds in human urine.

    (XLSX)

    pone.0321394.s001.xlsx (10.4KB, xlsx)
    S2 Table. Identified VOCs in a literature search of 12 relevant publications with their total number of references, chemical family, found concentration, and short description.

    (XLSX)

    pone.0321394.s002.xlsx (22KB, xlsx)
    S3 Table. Composition of artificial urine.

    (XLSX)

    pone.0321394.s003.xlsx (10.3KB, xlsx)
    S4 Table. List of behaviors assessed by video.

    (XLSX)

    pone.0321394.s004.xlsx (10.1KB, xlsx)
    S1 Fig. Bar charts showing the relative intensities of GC-MS peak areas of VOCs in the model urine matrix at the initial time (“t0”) and after 7 days of storage at 4°C (“t0 + 7 days”). The peak areas at the initial time (“t0”) are expressed as 100% reference values (blue bars). The “Ratio t0 + 7 days/t0” (red bars) indicates the percentage ratio of values obtained after 7 days of storage to the initial values. Error bars represent the average standard deviation (n = 3).

    (TIF)

    pone.0321394.s005.TIF (4.4MB, TIF)
    S2 Fig. Stability of amyl-acetate in water. The boxplot displays the interquartile range, with the central line representing the median. The whiskers extend to the range of the data (1.5 IQR from the quartiles), and the diamond-shaped dots indicate outliers. The missing part of the boxplot corresponds to 0 values, which are not visible due to the log scale used in the plot. The Y-axis represents the area under the curve refers to the integrated signal corresponding to a specific compound or ion as it elutes through the chromatographic column. This area is used to quantify the amount of a particular substance in the sample. The X-axis represents the theoretical concentration of Isoamyl Acetate in water.

    (TIF)

    S3 Fig. Stability of amyl-acetate in artificial urine. The boxplot displays the interquartile range, with the central line representing the median. The whiskers extend to the range of the data (1.5 IQR from the quartiles), and the diamond-shaped dots indicate outliers. The missing part of the boxplot corresponds to 0 values, which are not visible due to the log scale used in the plot. The Y-axis represents the relative response in GC-MS, which is the intensity of the analyte signal relative to the total ion current or to an internal standard, allowing for comparison across different concentrations and conditions. The X-axis represents the theoretical concentration of Isoamyl Acetate in urine.

    (TIF)

    pone.0321394.s007.TIF (4.7MB, TIF)
    Attachment

    Submitted filename: Response_to_reviewers_P3.docx

    pone.0321394.s009.docx (50.7KB, docx)

    Data Availability Statement

    The dataset and its corresponding data dictionary are publicly available on Figshare at https://figshare.com/s/d128cd03724e5be874ee.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES